系统性硬化症中mycophenolate mofetil-rituximab组合的评估:一项法国回顾性多中心研究 (MycRiSSc)

François Barde1, Kevin Chevalier2, Paul Decker3

  • 1Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases and Autoinflammatory Diseases of Ile de France, East and West, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (APHP), Université Paris Cité, Paris, France; Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.

Journal of autoimmunity
|October 16, 2025
PubMed
概括

菌酸莫菲蒂尔 (MMF) 和利图西马布 (RTX) 的组合有效地治疗系统性硬化症 (SSc) 中的皮肤和间歇性肺病 (ILD). 同时引入MMF和RTX为SSc患者提供了最好的结果.